Medical
Information
For medical information,
please call:
North America
877.ALNYLAM
(877.256.9526)
Europe
+31 20 369 7861
Email:
MEDINFO@ALNYLAM.COM
For country specific medical information details please navigate to the individual country sites
Adverse
Events/Product
Complaints
To report an adverse event
or to make a product
complaint, please call:
North America
877.ALNYLAM
(877.256.9526)
Europe
+31 20 369 7861
Email:
MEDINFO@ALNYLAM.COM
Clinical
Trials
For clinical trial inquiries, please call:
North America
877.ALNYLAM
(877.256.9526)
Europe
+31 20 369 7861
For more information please visit:
clinicaltrialinfo.alnylam.com
Other
Inquiries
Media:
MEDIA@ALNYLAM.COM
Investor Relations:
INVESTORS@ALNYLAM.COM
Business Development:
BUSINESSDEVELOPMENT@
ALNYLAM.COM
General:
INFO@ALNYLAM.COM
Alnylam Assist®
(Alnylam Patient Support):
833.256.2748
Compliance Helpline:
800.231.8685
helpline.alnylam.com
Alnylam Pharmaceuticals, Inc – Corporate Headquarters
675 West Kendall St
Cambridge, MA 02142
USA
Tel: 617.551.8200
Fax: 617.551.8101
Alnylam Pharmaceuticals – Norton Manufacturing Facility
20 Commerce Way
Norton, MA 02766
USA
Tel: 617.551.8200
Alnylam Netherlands B.V.
Cross Towers, 20e verdieping
Antonio Vivaldistraat 150
1083 HP Amsterdam
Nederland
Tel: 0800.403.0002 / 020.369.7850
Alnylam Japan KK
11th Floor of Pacific Century Place Marunouchi
1-11-1 Marunouchi, Chiyoda-ku
Tokyo 100-6211
Japan
Tel: 0120.970.347
You will be redirected to an external site that may include social media, event registration, or other third-party content related to Alnylam.
Please note that these external sites have their own terms of service and privacy policies, which may differ from those of Alnylam.
Proceed to Site